| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nivolumab mode of action | 0.96 | 0.9 | 7173 | 59 | 24 |
| nivolumab | 0.67 | 0.1 | 3455 | 88 | 9 |
| mode | 0.43 | 0.3 | 5920 | 12 | 4 |
| of | 1.71 | 0.8 | 381 | 97 | 2 |
| action | 1.58 | 0.2 | 1421 | 59 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nivolumab mode of action | 1.39 | 0.5 | 545 | 73 |
| mechanism of action of nivolumab | 1.19 | 0.5 | 488 | 6 |
| nivolumab duration of action | 0.7 | 0.9 | 2760 | 68 |
| nivolumab for renal cell mechanism of action | 1.28 | 0.1 | 8836 | 17 |
| nivolumab how does it work | 1.79 | 0.3 | 1594 | 72 |
| ipilimumab and nivolumab mechanism of action | 0.24 | 0.8 | 501 | 14 |
| nivolumab up to date | 1.44 | 0.4 | 9936 | 7 |
| nivolumab combination therapy in advanced | 0.41 | 0.3 | 7076 | 72 |
| what does nivolumab target | 0.87 | 0.4 | 5815 | 77 |
| nivolumab class of drug | 1.74 | 0.1 | 7989 | 71 |
| what is in nivolumab | 1.37 | 0.4 | 8560 | 24 |
| nivolumab side effects management | 1.59 | 0.1 | 8256 | 24 |
| what is nivolumab therapy | 0.19 | 0.2 | 963 | 34 |
| nivolumab used to treat | 0.6 | 1 | 7185 | 16 |
| nivolumab for the treatment of cancer | 1.23 | 0.2 | 1989 | 32 |
| what is nivolumab drug | 1.52 | 0.7 | 6390 | 49 |
| fiche info patient nivolumab | 1.75 | 0.1 | 2929 | 74 |
| nivolumab + ipilimumab | 0.51 | 0.1 | 1399 | 16 |
| fp+nivolumab | 0.22 | 0.5 | 3039 | 43 |
